Long-term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension

Yuichi Tamura, Asuka Furukawa, Yudai Tamura, Kenta Yamada, Hirohisa Taniguchi, Keiichi Fukuda, Akio Kawamura, Toru Satoh

Research output: Contribution to journalArticlepeer-review

Abstract

There was no structured method for safely transition from parenteral prostanoids to oral medication. We enrolled 37 idiopathic/hereditary pulmonary arterial hypertension patients receiving triple combination therapy including parenteral prostanoids into structured transition program to oral selexipag. Four (10.8%) patients successfully transitioned under the protocol, and all of them presented long-term safety.

Original languageEnglish
Article numbere12058
JournalPulmonary Circulation
Volume12
Issue number1
DOIs
Publication statusPublished - 2022 Jan

Keywords

  • prostanoids
  • pulmonary arterial hypertension
  • transition therapy

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Long-term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension'. Together they form a unique fingerprint.

Cite this